118 related articles for article (PubMed ID: 26424162)
21. High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors.
He S; Jain P; Lin B; Ferrer M; Hu Z; Southall N; Hu X; Zheng W; Neuenswander B; Cho CH; Chen Y; Worlikar SA; Aubé J; Larock RC; Schoenen FJ; Marugan JJ; Liang TJ; Frankowski KJ
ACS Comb Sci; 2015 Oct; 17(10):641-52. PubMed ID: 26332742
[TBL] [Abstract][Full Text] [Related]
22. Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivatives.
Krueger AC; Madigan DL; Beno DW; Betebenner DA; Carrick R; Green BE; He W; Liu D; Maring CJ; McDaniel KF; Mo H; Molla A; Motter CE; Pilot-Matias TJ; Tufano MD; Kempf DJ
Bioorg Med Chem Lett; 2012 Mar; 22(6):2212-5. PubMed ID: 22342631
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and characterization of 1'-C-cyano-2'-fluoro-2'-C-methyl pyrimidine nucleosides as HCV polymerase inhibitors.
Kirschberg TA; Mish MR; Zhang L; Squires NH; Wang KY; Cho A; Feng JY; Fenaux M; Babusis D; Park Y; Ray AS; Kim CU
Bioorg Med Chem Lett; 2015 Mar; 25(5):1040-3. PubMed ID: 25650256
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Anti-HCV Activities of 4'-Fluoro-2'-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4'-Fluoro-2'- C-methyluridine 5'-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection.
Wang G; Dyatkina N; Prhavc M; Williams C; Serebryany V; Hu Y; Huang Y; Wan J; Wu X; Deval J; Fung A; Jin Z; Tan H; Shaw K; Kang H; Zhang Q; Tam Y; Stoycheva A; Jekle A; Smith DB; Beigelman L
J Med Chem; 2019 May; 62(9):4555-4570. PubMed ID: 30951311
[TBL] [Abstract][Full Text] [Related]
25. Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action.
Windisch MP; Jo S; Kim HY; Kim SH; Kim K; Kong S; Jeong H; Ahn S; No Z; Hwang JY
Eur J Med Chem; 2014 May; 78():35-42. PubMed ID: 24675178
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and Antiviral Activity of a Series of 2'-
Dentmon ZW; Kaiser TM; Liotta DC
Molecules; 2020 Nov; 25(21):. PubMed ID: 33171951
[TBL] [Abstract][Full Text] [Related]
27. Discovery of the 2-phenyl-4,5,6,7-Tetrahydro-1H-indole as a novel anti-hepatitis C virus targeting scaffold.
Andreev IA; Manvar D; Barreca ML; Belov DS; Basu A; Sweeney NL; Ratmanova NK; Lukyanenko ER; Manfroni G; Cecchetti V; Frick DN; Altieri A; Kaushik-Basu N; Kurkin AV
Eur J Med Chem; 2015; 96():250-8. PubMed ID: 25890075
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and Anti-HCV Activity of Sugar-Modified Guanosine Analogues: Discovery of
Wang G; Dyatkina N; Prhavc M; Williams C; Serebryany V; Hu Y; Huang Y; Wu X; Chen T; Huang W; Rajwanshi VK; Deval J; Fung A; Jin Z; Stoycheva A; Shaw K; Gupta K; Tam Y; Jekle A; Smith DB; Beigelman L
J Med Chem; 2020 Sep; 63(18):10380-10395. PubMed ID: 32816483
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 2'-deoxy-2'-fluoro-2'-C-methyl spiro cyclopentyl carbocyclic uridine analog as potential inhibitors of HCV NS5B polymerase.
Singh US; Chu CK
Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):52-68. PubMed ID: 32310031
[TBL] [Abstract][Full Text] [Related]
30. The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479).
McGuigan C; Kelleher MR; Perrone P; Mulready S; Luoni G; Daverio F; Rajyaguru S; Le Pogam S; Najera I; Martin JA; Klumpp K; Smith DB
Bioorg Med Chem Lett; 2009 Aug; 19(15):4250-4. PubMed ID: 19505826
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives.
Peng HK; Lin CK; Yang SY; Tseng CK; Tzeng CC; Lee JC; Yang SC
Bioorg Med Chem Lett; 2012 Jan; 22(2):1107-10. PubMed ID: 22204909
[TBL] [Abstract][Full Text] [Related]
32. Phosphorodiamidates as a promising new phosphate prodrug motif for antiviral drug discovery: application to anti-HCV agents.
McGuigan C; Madela K; Aljarah M; Bourdin C; Arrica M; Barrett E; Jones S; Kolykhalov A; Bleiman B; Bryant KD; Ganguly B; Gorovits E; Henson G; Hunley D; Hutchins J; Muhammad J; Obikhod A; Patti J; Walters CR; Wang J; Vernachio J; Ramamurty CV; Battina SK; Chamberlain S
J Med Chem; 2011 Dec; 54(24):8632-45. PubMed ID: 22039920
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl purine nucleosides as inhibitors of hepatitis C virus RNA replication.
Clark JL; Mason JC; Hollecker L; Stuyver LJ; Tharnish PM; McBrayer TR; Otto MJ; Furman PA; Schinazi RF; Watanabe KA
Bioorg Med Chem Lett; 2006 Mar; 16(6):1712-5. PubMed ID: 16368235
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and anti-hepatitis C virus (HCV) activity of 3'-C-substituted-methyl pyrimidine and purine nucleosides.
Choi WJ; Kim YM; Kim HO; Lee HW; Kim DE; Park KS; Chong Y; Jeong LS
Bioorg Med Chem; 2010 Jul; 18(13):4812-20. PubMed ID: 20627592
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease.
Alexandre FR; Brandt G; Caillet C; Chaves D; Convard T; Derock M; Gloux D; Griffon Y; Lallos L; Leroy F; Liuzzi M; Loi AG; Moulat L; Musiu C; Parsy C; Rahali H; Roques V; Seifer M; Standring D; Surleraux D
Bioorg Med Chem Lett; 2015 Sep; 25(18):3984-91. PubMed ID: 26231161
[TBL] [Abstract][Full Text] [Related]
36. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors.
Hwang JY; Kim HY; Park DS; Choi J; Baek SM; Kim K; Kim S; Seong S; Choi I; Lee HG; Windisch MP; Lee J
Bioorg Med Chem Lett; 2013 Dec; 23(23):6467-73. PubMed ID: 24125883
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and anti-HCV activity of thiourea compounds.
Kang IJ; Wang LW; Lee CC; Lee YC; Chao YS; Hsu TA; Chern JH
Bioorg Med Chem Lett; 2009 Apr; 19(7):1950-5. PubMed ID: 19251415
[TBL] [Abstract][Full Text] [Related]
38. Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: from anti-pestivirus to anti-hepatitis C virus activity.
Puerstinger G; Paeshuyse J; De Clercq E; Neyts J
Bioorg Med Chem Lett; 2007 Jan; 17(2):390-3. PubMed ID: 17084081
[TBL] [Abstract][Full Text] [Related]
39. Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.
Mittapalli GK; Jackson A; Zhao F; Lee H; Chow S; McKelvy J; Wong-Staal F; Macdonald JE
Bioorg Med Chem Lett; 2011 Nov; 21(22):6852-5. PubMed ID: 21978675
[TBL] [Abstract][Full Text] [Related]
40. Cyclic monophosphate prodrugs of base-modified 2'-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication.
Gunic E; Girardet JL; Ramasamy K; Stoisavljevic-Petkov V; Chow S; Yeh LT; Hamatake RK; Raney A; Hong Z
Bioorg Med Chem Lett; 2007 May; 17(9):2452-5. PubMed ID: 17331721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
